Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | CCL2 | P13500 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30105986 | 1.00 | P2RX4 (0.40) | P2RX4POLBHTTALDH1A1MAPT | |
| SCHEMBL9755452 | 0.86 | P2RX4 (0.34) | P2RX4POLBALDH1A1MAPTKDM4E | |
| SCHEMBL8378960 | 0.85 | POLB (0.37) | P2RX4POLBALDH1A1KDM4EMEN1 | |
| SCHEMBL27287008 | 0.82 | MTNR1A (0.34) | P2RX4POLBHTTALDH1A1MAPT | |
| SCHEMBL27970744 | 0.81 | HTR2A (0.37) | POLBALDH1A1MAPTKDM4EMEN1 | |
| SCHEMBL30666690 | 0.81 | POLB (0.36) | P2RX4POLBALDH1A1MAPTKDM4E | |
| SCHEMBL629577 | 0.81 | POLB (0.36) | P2RX4POLBALDH1A1MAPTKDM4E | |
| SCHEMBL4372310 | 0.81 | LMNA (0.47) | POLBALDH1A1MAPTKDM4EMEN1 | |
| SCHEMBL29539865 | 0.81 | LMNA (0.47) | POLBALDH1A1MAPTKDM4EMEN1 | |
| SCHEMBL9309445 | 0.80 | HTR2A (0.38) | P2RX4POLBALDH1A1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5750767-A | REACTING PROTECTED AMINO ACID WITH FLUOROFORMAMIDINIUM SALT | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1998-05-12 | — | — | US | claimed |
| WO-1996004297-A1 | SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS PEPTIDE COUPLING REAGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-02-15 | — | — | WO | claimed |
| WO-1991005564-A1 | SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS PEPTIDE COUPLING REAGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-05-02 | — | — | WO | claimed |
| CN-116546990-B | CD73 inhibitor and pharmaceutical application thereof | RISEN (SUZHOU) PHARMA TECH Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-117940541-A | Cyclopropanated fragrance compounds | 西姆莱斯有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20230359119-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| CN-116546990-A | CD73 inhibitor and pharmaceutical application thereof | 润佳（苏州）医药科技有限公司 | 2023-08-04 | — | — | CN | disclosed |
| EP-4008708-A1 | FULLERENE DERIVATIVES FOR ORGANIC SEMICONDUCTORS | Nano-C, Inc. (US) | 2022-06-08 | — | — | EP | disclosed |
| EP-3157895-B9 | FULLERENE DERIVATIVES FOR ORGANIC SEMICONDUCTORS | NANO C INC (US) | 2022-03-30 | — | — | EP | disclosed |
| EP-3157895-B1 | FULLERENE DERIVATIVES FOR ORGANIC SEMICONDUCTORS | NANO C INC (US) | 2021-12-29 | — | — | EP | disclosed |
| CN-106458808-B | Fullerene derivative | 天光材料科技股份有限公司 | 2021-04-20 | — | — | CN | disclosed |
| EP-0807101-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 1997-11-19 | — | — | EP | disclosed |
| US-5674905-A | ADMINISTERING AS GASTRIN OR CHOLECYSTOKININ ANTAGONISTS | JAMES BLACK FOUNDATION LIMITED (GB) | 1997-10-07 | — | — | US | disclosed |
| EP-0655053-B1 | BICYCLOOCTANE AND BICYCLOHEPTANE DERIVATIVES | BLACK JAMES FOUNDATION (GB) | 1997-09-03 | — | — | EP | disclosed |
| WO-1996023760-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 1996-08-08 | — | — | WO | disclosed |
| WO-1996004297-A1 | SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS PEPTIDE COUPLING REAGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-02-15 | — | — | WO | disclosed |
| EP-0655053-A1 | BICYCLOOCTANE AND BICYCLOHEPTANE DERIVATIVES. | BLACK JAMES FOUNDATION (GB) | 1995-05-31 | — | — | EP | disclosed |
| WO-1994000421-A1 | BICYCLOOCTANE AND BICYCLOHEPTANE DERIVATIVES | JAMES BLACK FOUNDATION LIMITED (GB) | 1994-01-06 | — | — | WO | disclosed |
| EP-0496836-A4 | SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS PEPTIDE COUPLING REAGENTS | — | 1993-05-05 | — | — | EP | disclosed |
| EP-0496836-A1 | SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS PEPTIDE COUPLING REAGENTS. | RES CORP TECHNOLOGIES INC (US) | 1992-08-05 | — | — | EP | disclosed |